Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Carbohydrate Metabolism01:36

Carbohydrate Metabolism

10.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.7K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

499
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
499
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

232
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
232
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

852
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
852
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetic distal symmetric polyneuropathy: More than just "tingling in the feet".

Diabetes, obesity & metabolism·2025
Same author

Pseudoascites Due to Celiac Disease in a Patient with Type 1 Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2025
Same author

In adults with obesity and knee OA, adding weekly semaglutide to diet and activity counseling reduced weight and knee pain at 68 wk.

Annals of internal medicine·2025
Same author

Diabetic Charcot neuroarthropathy: A threat to both limb and life.

Diabetes, obesity & metabolism·2024
Same author

All That Glistens Is not Gold: Neuropathy in Diabetic Patients May not Be Exclusively due to Diabetes.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2024
Same author

The Role of Teplizumab in Newly Diagnosed Type 1 Diabetes.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2024
Same journal

Effect of Blood Donation in the Glycemic Control of Prediabetic Donors: A Blinded Randomized Controlled Trial.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same journal

Etomidate in Severe Cushing Syndrome: An Underutilized Bridge in Endocrine Emergency Care.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same journal

Insights from secular trend of major osteoporotic fractures in people with and without diabetes: 15-year population-based study (2009 - 2023).

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same journal

Early Metabolic Risk in Childhood Brain Cancer Survivors with Childhood-Onset Growth Hormone Deficiency.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same journal

The Use of Directed Ablative Techniques for Autonomously Functioning Thyroid Nodules: A Statement from the North American Society for Interventional Thyroidology.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same journal

North American Society for Interventional Thyroidology (NASIT) Statement on Directed Ablative Therapy for the Management of Cervical Recurrence of Papillary Thyroid Cancer.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
See all related articles

Related Experiment Video

Updated: May 29, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

193

Stroke in the Patient With Type 2 Diabetes.

Terri W Jerkins1, David S H Bell2

  • 1Midstate Endocrine Associates, Nashville, Tennessee.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|February 6, 2025
PubMed
Summary
This summary is machine-generated.

Type 2 diabetes mellitus (T2DM) significantly increases stroke risk and worsens outcomes. Newer recommendations and antidiabetic drugs show promise in preventing stroke and improving quality of life for individuals with T2DM.

Keywords:
GLP-1 receptor agonistsSGLT-2 inhibitorshemorrhagic strokeischemic strokemetabolic syndromethiazolidinedionestype 2 diabetes

More Related Videos

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo
10:39

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo

Published on: March 8, 2018

8.2K
Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

1.6K

Related Experiment Videos

Last Updated: May 29, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

193
Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo
10:39

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo

Published on: March 8, 2018

8.2K
Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

1.6K

Area of Science:

  • Neurology
  • Endocrinology
  • Cardiovascular Medicine

Background:

  • Type 2 diabetes mellitus (T2DM) elevates stroke risk by 1.5 to 3 times compared to normoglycemic individuals.
  • Despite traditional risk factor control, patients with T2DM experience higher recurrent stroke rates and poorer post-stroke quality of life.

Purpose of the Study:

  • To review the pathophysiology linking T2DM and increased stroke risk.
  • To summarize the effects of traditional and novel risk factor modifications on stroke prevention in T2DM.

Main Methods:

  • Review of multiple publications on T2DM and stroke pathophysiology.
  • Analysis of new publications on traditional and emerging risk factor modification strategies.

Main Results:

  • Refined traditional risk factor modification includes optimized lipid and blood pressure levels, and anticoagulation methods.
  • Emerging antidiabetic drugs, such as glucagon-like peptide-1 receptor agonists and pioglitazone, demonstrate efficacy in preventing primary and secondary strokes in diabetic patients.

Conclusions:

  • Stroke is a leading cause of death and disability globally, with T2DM exacerbating both risk and outcomes.
  • Implementing updated recommendations and novel therapeutic strategies can significantly improve stroke outcomes for individuals with T2DM.